NCT01048593View on ClinicalTrials.gov

Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Inflammatory Reaction Due to Ocular Lens Prosthesis
Interventions
DRUG

IBI-10090

Single intraocular injection

Trial Locations (1)

94024

Altos Eye Physicians, Los Altos

Sponsors
All Listed Sponsors
lead

ICON Bioscience Inc

INDUSTRY

NCT01048593 - Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery | Biotech Hunter | Biotech Hunter